What is TAOX's earnings growth forecast for 2026-2026?
(NASDAQ: TAOX) Tao Synergies's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Tao Synergies's earnings in 2025 is -$27,074,956.
In 2026, TAOX is forecast to generate -$51,118,576 in earnings, with the lowest earnings forecast at -$49,113,926 and the highest earnings forecast at -$52,622,064.
What is TAOX's revenue growth forecast for 2026-2026?
(NASDAQ: TAOX) Tao Synergies's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Tao Synergies's revenue in 2025 is $207,333.
In 2026, TAOX is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.
What is TAOX's forecast return on assets (ROA) for 2026-2026?
(NASDAQ: TAOX) forecast ROA is -278.44%, which is lower than the forecast US Biotechnology industry average of 13.31%.
What is TAOX's Earnings Per Share (EPS) forecast for 2026-2026?
(NASDAQ: TAOX) Tao Synergies's current Earnings Per Share (EPS) is -$17.06. In 2026, TAOX's EPS is forecast to hit -$7.17 (min: -$6.89, max: -$7.38).
What is TAOX's forecast return on equity (ROE) for 2026-2026?
(NASDAQ: TAOX) forecast ROE is -318.2%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.